ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Fengjiao Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0007-5347-8875; OpenAlex author ID A5100655113. Sources: OpenAlex.

Their work

Papers: 5 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 14

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers

Papers 5

KIF20B and MET, hub genes of DIAPHs, predict poor prognosis and promote pancreatic cancer progression. Co-author DOI 10.1016/j.prp.2023.155046 ↗
EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in Pancreatic Adenocarcinoma. Co-author DOI 10.31083/j.fbl2903119 ↗
Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-κB/JNK/ERK phosphorylation. Co-author DOI 10.1186/s10020-023-00648-z ↗
Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer. First author DOI 10.1186/s12920-022-01246-4 ↗
Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling. Co-author DOI 10.1186/s12885-021-08158-z ↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhen Chen · 5 shared papers, 2021–2024 · strength 1.00
Chien‐shan Cheng · 4 shared papers, 2021–2024 · strength 0.78
Yanhua Jing · 3 shared papers, 2022–2024 · strength 0.66
Ke Zhang · 3 shared papers, 2022–2024 · strength 0.66
Juying Jiao · 3 shared papers, 2023–2024 · strength 0.65
Linjie Ruan · 3 shared papers, 2023–2024 · strength 0.65
Zhangqi Cao · 2 shared papers, 2024 · strength 0.43
- Paper KIF20B and MET, hub genes of DIAPHs, predict poor prognosis and promote pancreatic cancer progression. DOI 10.1016/j.prp.2023.155046 ↗
- Paper EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in Pancreatic A… DOI 10.31083/j.fbl2903119 ↗
Peiwen Yang · 1 shared paper, 2023 · strength 0.22
- Paper Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-κB/JNK/ERK phosphor… DOI 10.1186/s10020-023-00648-z ↗
Shulin Yu · 1 shared paper, 2021 · strength 0.12
- Paper Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling. DOI 10.1186/s12885-021-08158-z ↗
Yawen Geng · 1 shared paper, 2021 · strength 0.12
- Paper Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling. DOI 10.1186/s12885-021-08158-z ↗
Chao Qu · 1 shared paper, 2021 · strength 0.12
- Paper Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling. DOI 10.1186/s12885-021-08158-z ↗
Lai Wang · 1 shared paper, 2021 · strength 0.12
- Paper Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling. DOI 10.1186/s12885-021-08158-z ↗
Zhiqiang Meng · 1 shared paper, 2021 · strength 0.12
- Paper Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling. DOI 10.1186/s12885-021-08158-z ↗
Lianyu Chen · 1 shared paper, 2021 · strength 0.12
- Paper Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling. DOI 10.1186/s12885-021-08158-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.